• Kyodo, Reuters

  • SHARE

The government has decided to postpone approving Fujifilm Holdings Corp.'s Avigan drug for the treatment of COVID-19 until June or later, health minister Katsunobu Kato said Tuesday.

Prime Minister Shinzo Abe had said earlier this month he hoped the drug, known generically as favipiravir, would be approved some time in May if its efficacy and safety could be confirmed.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)